Lonza Expands its Capsugel® Capsule Offering to Include Titanium Dioxide-Free White Hard Gelatin Capsules

Basel, Switzerland, 09 May 2022 – Lonza has expanded its Capsugel® offering with a titanium dioxide-free (TiO2-free) white hard gelatin capsule, fulfilling the evolving demand of its customers to meet new titanium dioxide-free requirements for foods in the European Union.

This novel opacifying technology leverages the functionality of crystalized salts to provide the same whiteness and masking as capsules containing TiO2. In an internal head-to-head comparison study, Lonza’s TiO2 alternative solution provided excellent light protection and opacity compared to other TiO2 alternatives as well as capsules produced with TiO2.

  • New hard gelatin capsule provides a bright white color, while meeting titanium dioxide-free requirements for foods in the European Union
  • The new capsule features an alternative opacifying technology, offering an excellent masking solution, and has a superior protection of the fill formulation from light.

Stef Vanquickenborne, Vice President, Head of Capsules & Health Ingredients Research and Development, Lonza commented: “As a leader in capsule design and manufacturing, we have leveraged our experience and expertise to develop a opacifying formulation to meet the evolving requirements of our customers. This new capsule joins an already existing offering of titanium dioxide-free capsules including Capsugel® White Opal® HPMC capsule.”

Download the full press release

Find further articles on Titanium Dioxide (TiO2) topics here


Experts panel discussion on the future use of Titanium Dioxide (E171) in Pharma

Watch and read it here

Experts panel on the future use of Titanium Dioxide (E171) in Pharma
Experts panel discussion on the future use of Titanium Dioxide (E171) in Pharma
You might also like